Highlights Closing the oversubscribed brokered offering for $5.75 million of gross proceeds. Participation by all directors and officers of the Company, maintaining…
Category:
Investing
-
-
-
Investing
Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure
Data demonstrates improvement in cardiac function and reductions in cardiac hypertrophy, remodeling, inflammation, and cell death – key underlying mechanisms in heart…
-
-
-
Investing
Freegold Achieves Over 93% Recovery Using Albion Process oxidation-CIL Additional Metallurgical Work Remains Ongoing
Total gold recovery of over 93% from a composite comprised of core from 8 drill holes representing the Dolphin/Cleary resource area. The flowsheet…
-
Investing
Red Metal Resources Planning 2025 Work Program on 100% Owned Hydrogen-Prospective Mineral Claim Package Spanning Quebec and Ontario
Red Metal Resources Ltd. (CSE: RMES) (OTC Pink: RMESF) (FSE: I660) (‘Red Metal’ or the ‘Company’) is pleased to announce that it…
-
-
-
Investing
Lode Gold Sets Date for Shareholder Meeting to Approve Plan of Arrangement for Spinout Monday, March 10, 2025 at 10AM MST
Lode Gold Resources Inc. (TSXV: LOD) (OTCQB: LODFF) (‘Lode Gold’ or the ‘Company’) is pleased to announce that a shareholder meeting has…